Back
Bicara Therapeutics Vs. Carvana Industry Stock Comparison
Buy
62
BCAX
Bicara Therapeutics
Last Price:
$13.25
Seasonality Move:
--
Sell
49
CVNA
Carvana
Last Price:
$192.00
Seasonality Move:
87.96%
Buy
62
Bicara Therapeutics (BCAX)
is a Buy
Is Bicara Therapeutics a Buy, Sell or Hold?
-
The current Bicara Therapeutics [BCAX] share price is $13.24. The Score for BCAX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
BCAX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Carvana (CVNA)
is a Sell
Is Carvana a Buy, Sell or Hold?
-
CVNA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BCAX Stock Price Chart
What is Bicara Therapeutics's stock price today?
-
The Bicara Therapeutics share price today is $13.24Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCAX is experiencing slight buying pressure.
BCAX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 48.72 | Sell |
Chaikin Money Flow: | 231121 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.36 - 14.42) | Sell |
Bollinger Bands (100): | (12.61 - 20.81) | Sell |
CVNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 26.65 | Buy |
Relative Strength Index (14 RSI): | 44.82 | Sell |
Chaikin Money Flow: | 3504375 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (178 - 254.34) | Sell |
Bollinger Bands (100): | (201.74 - 258.36) | Sell |
BCAX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.93 | Buy |
20-day SMA: | 13.44 | Sell |
50-day SMA: | 13.1 | Buy |
200-day SMA: | 0 | Buy |
8-day EMA: | 13.15 | Buy |
20-day EMA: | 13.33 | Sell |
50-day EMA: | 13.86 | Sell |
200-day EMA: | 11.22 | Buy |
CVNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 179.08 | Buy |
20-day SMA: | 200.61 | Sell |
50-day SMA: | 225.06 | Sell |
200-day SMA: | 187.11 | Buy |
8-day EMA: | 74.48 | Buy |
20-day EMA: | 34.16 | Buy |
50-day EMA: | 14.47 | Buy |
200-day EMA: | 3.73 | Buy |
Bicara Therapeutics Earnings Growth & BCAX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.18 per share, and a decrease next year of $0.54 per share.
Carvana Earnings Growth & CVNA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.68 per share, an increase next quarter of $0.19 per share, an increase this year of $1.90 per share, and an increase next year of $1.46 per share.
Bicara Therapeutics Technical Analysis
Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Carvana Technical Analysis
Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |